High TGF-β1 expression predicts poor disease prognosis in hepatocellular carcinoma patients

Transforming growth factor beta (TGF-β) promotes the pathogenesis of hepatocellular carcinoma (HCC). We evaluated the associations between TGF-β1 expression and clinicopathological parameters in HCC patients from The Cancer Genome Atlas (TCGA), as well as the prognostic power of TGF-β1 expression. E...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Li, Yuan, Xiao-Qing, Zhang, Chao-Yang, Ye, Fei, Zhou, Hui-Fang, Li, Wen-Ling, Liu, Zhao-Yang, Zhang, Ya-Qin, Pan, Xi, Li, Guan-Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470976/
https://www.ncbi.nlm.nih.gov/pubmed/28415739
http://dx.doi.org/10.18632/oncotarget.16166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470976/
https://www.ncbi.nlm.nih.gov/pubmed/28415739
http://dx.doi.org/10.18632/oncotarget.16166

Ejemplares similares